Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3780 |  SEER Seer, Inc. - Class A Common Stock | 2.17 USD | -1.81% | -3.56% | +11.86% | -6.47% | 120.16 M USD | ||
| 3785 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.78 USD | +1.71% | -11.00% | -3.78% | -78.81% | 119.29 M USD | ||
| 3786 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 30.08 USD | -3.00% | -6.58% | -8.85% | +46.73% | 118.94 M USD | ||
| 3791 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 1.99 USD | -4.78% | -28.93% | -56.64% | -51.23% | 118.18 M USD | ||
| 3795 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.99 USD | +1.63% | +3.96% | +8.24% | -20.29% | 117.05 M USD | ||
| 3811 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 4.07 USD | -2.63% | -11.90% | -19.72% | -37.48% | 113.37 M USD | ||
| 3815 |  GNLX Genelux Corporation - Common Stock | 2.50 USD | -0.79% | -1.96% | -1.96% | -54.46% | 113.11 M USD | ||
| 3819 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.09 USD | -6.03% | -11.38% | -17.42% | -58.24% | 112.70 M USD | ||
| 3824 |  VANI Vivani Medical, Inc. - Common Stock | 1.23 USD | -3.15% | -0.81% | -6.11% | -12.14% | 110.95 M USD | ||
| 3825 |  LENZ LENZ Therapeutics, Inc. - Common Stock | 3.53 USD | -2.49% | -8.07% | -27.22% | -89.14% | 110.91 M USD | ||
| 3827 |  IFRX InflaRx N.V. - Common Stock | 1.53 USD | -1.92% | -12.07% | -25.37% | +5.52% | 110.61 M USD | ||
| 3828 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.79 USD | -2.47% | -2.47% | -7.06% | +64.58% | 110.12 M USD | ||
| 3845 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.81 USD | -1.09% | -5.24% | -12.14% | -58.58% | 103.99 M USD | ||
| 3849 |  IMUX Immunic, Inc. - Common Stock | 7.56 USD | -0.92% | -13.10% | -37.26% | +721.74% | 103.15 M USD | ||
| 3850 |  AARD Aardvark Therapeutics, Inc. - Common Stock | 4.71 USD | -5.04% | -12.29% | -3.29% | -62.65% | 103.08 M USD | ||
| 3856 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 5.27 USD | -4.01% | -19.66% | -39.49% | -68.25% | 101.93 M USD | ||
| 3858 |  ANIX Anixa Biosciences, Inc. - Common Stock | 2.91 USD | -1.36% | +2.83% | +5.43% | -41.09% | 101.16 M USD | ||
| 3866 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.37 USD | +3.79% | +7.03% | -25.14% | -22.16% | 99.30 M USD | ||
| 3890 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.23 USD | -1.49% | +11.88% | -7.14% | -37.42% | 92.65 M USD | ||
| 3897 |  EQ Equillium, Inc. - Common Stock | 1.44 USD | +3.60% | -7.10% | -43.31% | 0.00% | 91.31 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |